Citation: G. Grugni et al., Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome, J ENDOC INV, 24(5), 2001, pp. 340-348
Authors:
Finelli, P
Giardino, D
Russo, S
Gottardi, G
Cogliati, F
Grugni, G
Natacci, F
Larizza, L
Citation: P. Finelli et al., Refilled FISH characterization of a de novo 1p22-p36.2 paracentric inversion and associated 1p21-22 deletion in a patient with signs of 1p36 microdeletion syndrome, AM J MED G, 99(4), 2001, pp. 308-313
Authors:
Lee, PDK
Allen, DB
Angulo, MA
Cappa, M
Carrel, AL
Castro-Magana, M
Chiumello, G
Davies, PSW
Eiholzer, U
Grugni, G
Hauffa, BP
Hintz, RL
Lammer, C
Mogul, HR
Myers, SE
Partsch, CJ
Pescovitz, OH
Ritzen, EM
Rosenfeld, RG
Sipila, I
Wilson, DM
Citation: Pdk. Lee et al., Consensus statement - Prader-Willi syndrome: Growth hormone (GH)/insulin-like growth factor axis deficiency and GH treatment, ENDOCRINOLO, 10(4), 2000, pp. 71S-73S
Citation: G. Guzzaloni et al., Differences of hexarelin-induced prolactin and cortisol responses between prepubertal and early pubertal short children and lack of correlation with gonadotropin-releasing hormone-induced gonadotropin response, J PED END M, 13(7), 2000, pp. 907-912
Authors:
Guzzaloni, G
Grugni, G
Minocci, A
Moro, D
Morabito, F
Citation: G. Guzzaloni et al., Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test, INT J OBES, 24(6), 2000, pp. 772-776
Citation: G. Guzzaloni et al., Hexarelin-induced growth hormone response in short stature. Comparison with growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen, J ENDOC INV, 22(5), 1999, pp. 360-368